SCHEMBL12103752

SCHEMBL12103752

COC(=O)c1cc(C(C)(C)C)cc(NC(=O)c2cc3cccc(CN4CCN(C(=O)[C@@H]5CCCN5C)CC4)c3n2C)c1OC

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACKR3 P25106 3/20 0.37
DHODH Q02127 2/20 0.35
MAPK14 Q16539 1/20 0.35
EPHX2 P34913 1/20 0.34
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 1/20 0.34
SSTR5 P35346 1/20 0.34
LMNA P02545 1/20 0.33
TP53 P04637 1/20 0.33
MAPT P10636 1/20 0.33
FAAH O00519 2/20 0.33
CFD P00746 1/20 0.33
KLK7 P49862 1/20 0.33
LYN P07948 1/20 0.33
MAPK9 P45984 1/20 0.33
TSHR P16473 1/20 0.33
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
RORC P51449 1/20 0.32
GSK3A P49840 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1302235 1.00 ACKR3 (0.37) ACKR3DHODHMAPK14EPHX2KDM4E
SCHEMBL690275 0.95 ACKR3 (0.37) ACKR3DHODHMAPK14EPHX2KDM4E
SCHEMBL12103772 0.95 ACKR3 (0.37) ACKR3DHODHMAPK14EPHX2KDM4E
SCHEMBL691285 0.94 ACKR3 (0.36) ACKR3DHODHMAPK14EPHX2KDM4E
SCHEMBL690018 0.94 ACKR3 (0.36) ACKR3DHODHMAPK14EPHX2KDM4E
SCHEMBL691171 0.93 ACKR3 (0.36) ACKR3DHODHMAPK14EPHX2KDM4E
SCHEMBL689945 0.93 MAPK14 (0.43) ACKR3DHODHMAPK14SSTR5LYN
SCHEMBL690164 0.93 ACKR3 (0.36) ACKR3DHODHMAPK14EPHX2KDM4E
SCHEMBL690523 0.93 ACKR3 (0.36) ACKR3DHODHMAPK14EPHX2KDM4E
SCHEMBL689590 0.92 ACKR3 (0.38) ACKR3DHODHMAPK14EPHX2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110269737-A1 7-(Piperazine-1-Ymethyl)-1H-Indole-2-Carboxylic Acid (Phenyl)-Amide Derivatives and Allied Compounds as P38 Map Kinase Inhibitors for the Treatment of Respiratory Diseases BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-11-03 US disclosed
US-20110269737-A1 7-(Piperazine-1-Ymethyl)-1H-Indole-2-Carboxylic Acid (Phenyl)-Amide Derivatives and Allied Compounds as P38 Map Kinase Inhibitors for the Treatment of Respiratory Diseases BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-11-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110269737-A1 7-(Piperazine-1-Ymethyl)-1H-Indole-2-Carboxylic Acid (Phenyl)-Amide Derivatives and Allied Compounds as P38 Map Kinase Inhibitors for the Treatment of Respiratory Diseases MAPKAPK2, MAPKAPK5, MAPK7 ACKR3 985/4885DHODH 3745/4885MAPK14 19/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.